<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04322916</url>
  </required_header>
  <id_info>
    <org_study_id>20081020_Protocol_E_vitamys_V1</org_study_id>
    <nct_id>NCT04322916</nct_id>
  </id_info>
  <brief_title>Clinical Study With the RM Pressfit Vitamys Cup in Combination With a Mathys Stem</brief_title>
  <official_title>Clinical Study With the RM Pressfit Vitamys Cup in Combination With a Mathys Stem</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mathys Ltd Bettlach</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mathys Ltd Bettlach</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is the evaluation of the clinical and radiological short- to
      long-term safety and performance of the RM Pressfit vitamys cup. The data will be used for an
      ongoing evaluation of the product safety and performance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective multicenter follow-up study which examines the short- to long-term post-market
      clinical data on the safety and performance of the RM Pressfit vitamys cup. In total 675
      participants in 9 clinics are included in this international multicenter study.

      The primary endpoint of the study is the Harris Hip Score (HHS) 2 years after surgery.

      The following parameters will be collected during the regular clinical and radiological
      follow-up: Harris Hip Score, radiographic evaluation and detection of adverse events.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 15, 2009</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Actual">March 28, 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Harris Hip Score (modified after Haddad et al, 1990)</measure>
    <time_frame>2 years</time_frame>
    <description>The primary endpoint of the study is the Harris Hip Score (HHS) 2 years after surgery. The HHS is a measure of dysfunction so the higher the score, the better the outcome for the individual. The maximum score possible is 100. Results can be interpreted with the following: &lt;70 = poor result; 70-80 = fair, 80-90 = good, and 90-100 = excellent.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiographic evaluation</measure>
    <time_frame>6-12 weeks - 10 years</time_frame>
    <description>The second endpoint of interest is the occurence of osteolysis around the cup</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>6-12 weeks - 10 years</time_frame>
    <description>Reporting of Adverse Events</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">675</enrollment>
  <condition>Arthropathy of Hip</condition>
  <condition>Hip Replacement</condition>
  <arm_group>
    <arm_group_label>RM Pressfit vitamys</arm_group_label>
    <description>Participants treated with a RM Pressfit vitamys hip cup in combination with a Mathys hip stem</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RM Pressfit vitamys</intervention_name>
    <description>Implantation of a RM Pressfit vitamys hip cup</description>
    <arm_group_label>RM Pressfit vitamys</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        according to Eligibility Criteria
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent form (signed by participant and investigator)

          -  Primary implantation

          -  Age at inclusion: Between 18 and 95 years old

          -  Willing to participate in the follow-up

        Exclusion Criteria:

          -  Missing Informed consent form

          -  Known or suspected non-compliance (e.g. drug or alcohol abuse)

          -  Enrollment of the investigator, his/her family, employees and other dependent persons

          -  Patient younger than 18 years old

          -  Revision surgery

          -  Presence of sepsis or malignant tumors

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 24, 2020</study_first_submitted>
  <study_first_submitted_qc>March 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2020</study_first_posted>
  <last_update_submitted>March 26, 2020</last_update_submitted>
  <last_update_submitted_qc>March 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Primary osteoarthritis</keyword>
  <keyword>Secondary osteoarthritis</keyword>
  <keyword>Inflammatory arthritis</keyword>
  <keyword>Congenital dysplasia</keyword>
  <keyword>Femoral head fracture</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

